Progress in retarding the progression of advanced chronic kidney disease: Grounds for optimism

Kidney International

Volumn 70, Issue SUPPL. 104, 2006, Pages

  Batlle, D ^a,b   Ramadugu, P ^a   Soler, M J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic kidney disease; Glomerular filtration rate; Renal outcomes and progression

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENAZEPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; RAMIPRIL;

ANEMIA; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; COHORT ANALYSIS; CREATININE BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN RESTRICTION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 33751091733     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001976     Document Type: Article

References (30)

1. Collins AJ, Li S, Gilbertson DT et al. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int 2003; 64(Suppl 87): S24-S31.
2. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.
3. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307: 652-659.
4. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-1666.
5. Mackenzie HSTM, Luyckx VA, Brenner BM. Adaptation to nephron loss. In: Brenner BM (ed) The Kidney. vol 2. WB Saunders: Philadelphia, 2000 pp, 1901-1942.
6. Mitch WE, Walser M, Buffington GA et al. A simple method of estimating progression of chronic renal failure. Lancet 1976; 2: 1326-1328.
7. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663.
8. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
9. Remuzzi A, Fassi A, Bertani T et al. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis 1999; 34: 626-632.
10. Hou FF, Zhang X, Zhang GH et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 2006; 354: 131-140.
11. Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51: 1908-1919.
12. Ruggenenti P, Perna A, Remuzzi G. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol 2001; 12: 2832-2837.
13. Serrano AHJ, Ghossein C, Nishi L et al. Stabilization of GFR in advanced chronic kidney disease: A two-year follow up of a cohort of CKD patients stages 4 and 5. Adv Chronic kidney Dis 2006 in press.
14. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997; 349: 1857-1863.
15. National Institutes of Diabetes and Digestive and Kidney Disease. National Kidney Disease Education Program (NKDEP). avaible at: http://www.nkdep.nih.gov,accesed: 21 June 2002.
16. Nissenson AR, Collins AJ, Hurley J et al. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol 2001; 12: 1713-1720.
17. Ghossein C, Serrano A, Rammohan M et al. The role of comprehensive renal clinic in chronic kidney disease stabilization and management: the Northwestern experience. Semin Nephrol 2002; 22: 526-532.
18. St Peter WL, Schoolwerth AC, McGowan T et al. Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis 2003; 41: 903-924.
19. Levin A, Lewis M, Mortiboy P et al. Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis 1997; 29: 533-540.
20. Singh AK. The Emergence of the CKD Clinic: Modeling Practices for Excellence CME. avaible at: http://medscape.com/viewprogram/193 Accesed: 3 July 2002.
21. Lenz O, Mekala DP, Patel DV et al. Barriers to successful care for chronic kidney disease. BMC Nephrol 2005; 6: 11.
22. Go ACG, Fan D, McCulloch C, Hsu C. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
23. Paparello J, Kshirsagar A, Batlle D. Comorbidity and cardiovascular risk factors in patients with chronic kidney disease. Semin Nephrol 2002; 22: 494-506.
24. Curtis BM, Ravani P, Malberti F et al. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 2005; 20: 147-154.
25. Ravani P, Marinangeli G, Tancredi M et al. Multidisciplinary chronic kidney disease management improves survival on dialysis. J Nephrol 2003; 16: 870-877.
26. Obrador GT, Pereira BJ, Kausz AT. Chronic kidney disease in the United States: an underrecognized problem. Semin Nephrol 2002; 22: 441-448.
27. Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Physician 2005; 72: 1723-1732.
28. Harris LE, Luft FC, Rudy DW et al. Effects of multidisciplinary case management in patients with chronic renal insufficiency. Am J Med 1998; 105: 464-471.
29. US Renal Data System. USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the Unites States. In: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2003.
30. US Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the Unites States. In: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2005.